Israel Institute for Biological Research

Israel Institute for Biological Research (IIBR) is an Israeli research and development laboratory ^[1] It is under the jurisdiction of the Prime Minister's Office^[2] that works in close cooperation with Israeli government agencies. IIBR has many public projects on which it works with international research organizations (governmental and non-governmental) and universities. It has approximately 350 employees, 150 of whom are scientists. Its research findings are often published in national and international scientific publications.^[1] It is widely believed to be involved in the manufacturing of biological and chemical weapons.^[3] The IIBR is currently developing a COVID-19 vaccine Brilife.^[4]

^ ^a ^b IIBR website
^ Cite error: The named reference Ostrovsky was invoked but never defined (see the help page).
^ Ginsburg, Mitch. "'Should there be a need': The inside story of Israel's chemical and biological arsenal". www.timesofisrael.com. Retrieved 2020-05-07.
^ "Israel names its vaccine candidate: Brilife - The Jerusalem Post". Archived from the original on 2020-10-19.

[website2-1] IIBR website

[Ostrovsky-2] Cite error: The named reference Ostrovsky was invoked but never defined (see the help page).

[:0-3] Ginsburg, Mitch. "'Should there be a need': The inside story of Israel's chemical and biological arsenal". www.timesofisrael.com. Retrieved 2020-05-07.

[4] "Israel names its vaccine candidate: Brilife - The Jerusalem Post". Archived from the original on 2020-10-19.

[1]

[2]

[3]

[4]